RxDoctor Payments Data

Jenna Clark

Family · Derry, NHNPI 1457027583

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,272, more than ten times the $20 reported in 2021. Among family clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,580in general payments, 2019–2025

Across 93 payments — averaging $27.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$374
  • AstraZeneca$343
  • AbbVie$286
  • Inspire Medical Systems, Inc.$214
  • Johnson & Johnson$208
  • Novo Nordisk$178
  • plus $979 from 16 others

What the payments were for

  • Food & beverage$2,580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,580 in reported general payments places this provider in the 90th percentile of 713 family providers in New Hampshire.

See all family providers in New Hampshire

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$12,845
Divalproex Sodium ErDivalproex Sodium17$2,310
Levothyroxine Sodium37$469
Atorvastatin Calcium47$407
Bupropion XlBupropion Hcl13$300
Lisinopril32$288
Albuterol Sulfate HfaAlbuterol Sulfate24$282
Gabapentin34$271
Amlodipine Besylate22$243
Pantoprazole Sodium16$205
Omeprazole17$190
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst23$157
Losartan Potassium15$153
Sertraline Hcl17$134
Tamsulosin Hcl11$126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$374$12,84515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 713 family providers in New Hampshire.

Other family in Derry

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →